Home » Newsletters » BioWorld Science

BioWorld Science

May 18, 2005

View Archived Issues

Astressin-2B reduces enterotoxin-mediated inflammatory processes

SLV-317 exerts antiinflammatory effects in experimental ileitis and colitis

Chugai reports domestic and overseas progress

Updated results for Genasense in CLL

Animal data on SP-304

Bionomics receives grant extension for CNS drug development

Talotrexin enters new phase I/II study for ALL

New phase Ib/II study of ADH-1

Mera and Rincon announce protein expression system research collaboration

Sorafenib plus chemotherapy studied in new phase III trial

Low incidence of anemia found with viramidine plus peginterferon alfa-2a in hepatitis C patients

Good safety profile found for multiple doses of VX-950 in healthy subjects

New data on the safety and pharmacokinetics of CpG-10101 in hepatitis C

SCR-011, a therapeutic candidate for ocular neovascularization

MB-500 promotes corneal wound healing

Antisense hTERT shows potential as a gastric cancer therapy

Amarillo receives SBIR grant for H. pylori vaccine development work

New stem cell trial to begin in heart failure patients

Piperazine derivative shows anxiolytic and antidepressant activity in preclinical studies

Novel benzodiazepine derivatives possess prolonged anticonvulsant properties

Recent patents disclose novel therapeutic agents for cancer

Remicade approved for psoriatic arthritis

Traditional approval for Trizivir

Novel SERMs emerge from GlaxoSmithKline research

Vertex patents voltage-gated sodium channel inhibitors for treatment of pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...